EpiVax
PrivateLast Round
M&A
Apr 2, 2026
Total Funding Raised
$4.6M
Company Overview
EpiVax is a biotechnology company that provides immunoinformatics tools and services for vaccine and biologics design.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiVax Comps
Public and private peers based on sector, stage, and business model.
EpiVax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 2, 2026 | ||||
| Grant | Sep 12, 2022 | ||||
| Grant | May 18, 2018 | ||||
| Grant | Dec 19, 2017 | ||||
| Grant | Apr 10, 2012 |
EpiVax Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2026
Funding round led by SV Health Investors.
- Sep 12, 2022
$2M grant from the Food and Drug Administration.
EpiVax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpiVax's valuation, stock price, and market status.
